These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 4342406)

  • 1. Immunologic impairment in bronchogenic carcinoma: a study of lymphocyte response to phytohemagglutinin.
    Han T; Takita H
    Cancer; 1972 Sep; 30(3):616-20. PubMed ID: 4342406
    [No Abstract]   [Full Text] [Related]  

  • 2. Skin test in bronchogenic carcinoma. I. Correlation of the immunological status and the extent of the disease.
    Takita H; Brugarolas A
    J Surg Oncol; 1973; 5(4):315-8. PubMed ID: 4355620
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunologic status in lung cancer.
    Brugarolas A; Takita H
    Chest; 1973 Oct; 64(4):427-30. PubMed ID: 4355273
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro lymphocyte blastogenesis: a prognostic test in patients with neoplastic disease.
    Han T
    J Surg Oncol; 1973 Jun; 5(6):567-74. PubMed ID: 4129688
    [No Abstract]   [Full Text] [Related]  

  • 5. [Delayed immunity in bronchial cancer: lymphocyte activation in culture with phytohemagglutinins and tuberculin PPD compared with the skin response to tubercular antigens].
    Piacentini G; Ferrari S; Megale C; Ippoliti F
    Boll Ist Sieroter Milan; 1973; 52(3):230-6. PubMed ID: 4762779
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunocompetence of patients with bronchogenic carcinoma.
    Olkowski ZL; McLaren JR; Mansour KA
    Ann Thorac Surg; 1976 Jun; 21(6):546-51. PubMed ID: 179484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immune status of patients with bronchial cancer].
    Aulenbacher P; Manke HG; Drings P
    Klin Wochenschr; 1987 May; 65(10):445-52. PubMed ID: 3037180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diminished lymphocyte responses to phytohemagglutinin in lung cancer.
    Hadjipetrou-Kourounakis L; Tsougranis A
    Biochem Exp Biol; 1980; 16(4):357-64. PubMed ID: 6285942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: Evaluation of immune status in tumor patients.
    Vetto RM; Burger DR; Lilley DP
    Arch Surg; 1974 Apr; 108(4):558-60. PubMed ID: 4131415
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumor associated antigen with pulmonary neoplasms.
    Lo Gerfo P; Herter FP; Braun J; Hansen HJ
    Ann Surg; 1972 Apr; 175(4):495-500. PubMed ID: 4336486
    [No Abstract]   [Full Text] [Related]  

  • 11. Mixed lymphocyte reactivity of patients with solid tumors.
    Harris J; Stewart TH
    Oncology; 1974; 30(1):33-42. PubMed ID: 4280032
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of phytohemagglutinin-induced in vitro lymphocyte transformation by serum from patients with carcinoma.
    Sample WF; Gertner HR; Chretien PB
    J Natl Cancer Inst; 1971 Jun; 46(6):1291-7. PubMed ID: 5088049
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum factors inhibiting E-rosette formation in patients with lung malignancies.
    Saiz-Garcia F; Rodriguez-Valverde V
    Bull Cancer; 1981; 68(4):346-9. PubMed ID: 6274454
    [No Abstract]   [Full Text] [Related]  

  • 14. Microcytotoxicity assays of tumor immunity in patients with bronchogenic carcinoma correlated with clinical status.
    Pierce GE; DeVald B
    Cancer Res; 1975 Dec; 35(12):3577-84. PubMed ID: 1192421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulation by bronchial lavage cells in normal individuals and patients with bronchogenic carcinoma.
    Weissman DN; deShazo RD; Banks DE; Baser Y
    Am J Med Sci; 1986 Oct; 292(4):187-92. PubMed ID: 3019138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of CCNU (NSC-79037) on bronchogenic carcinoma.
    Takita H; Brugarolas A
    J Natl Cancer Inst; 1973 Jan; 50(1):49-53. PubMed ID: 4348225
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunological monitoring of patients with carcinoma of the lung. Study method and preliminary research].
    Banna P; Stivala F; Murabito R; Cordopatri F; Saggio A; Mosca F; Cinà C
    Chir Ital; 1979 Dec; 31(6):1297-1313. PubMed ID: 233422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymus-dependent lymphocyte levels during radiation therapy for bronchogenic and esophageal carcinoma: correlations with clinical course in responders and nonresponders.
    Dellon AL; Ptovin C; Chretien PB
    Am J Roentgenol Radium Ther Nucl Med; 1975 Mar; 123(3):500-11. PubMed ID: 164781
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro methods of assessing lymphocyte transformation in patients undergoing radiotherapy for bronchogenic cancer.
    Jenkins VK; Olson MH; Ellis HN
    Tex Rep Biol Med; 1973; 31(1):19-28. PubMed ID: 4708575
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-specific immunostimulation in bronchogenic cancer.
    Israel L
    Scand J Respir Dis Suppl; 1974; 89():95-105. PubMed ID: 4370224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.